Does Histology Predict Survival of Advanced Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy? An Analysis of the Eastern Cooperative Oncology Group Study...

Por Hoang, Tien, Dahlberg, Suzanne E., Schiller, Joan H., Johnson, David H.
Publicado no Lung Cancer (2013)

Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4...

Por Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.
Publicado em 2010

Lung cancer diagnosed in the young is associated with enrichment for targetable genomic alterations and poor prognosis

Por Sacher, Adrian G., Dahlberg, Suzanne E., Heng, Jennifer, Mach, Stacy, Jänne, Pasi A., Oxnard, Geoffrey R.
Publicado no JAMA Oncol (2016)

Prognostic Models to Predict Survival in Non-Small Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab

Por Hoang, Tien, Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.
Publicado em 2012

Clinical Course and Outcome in Children with Acute Lymphoblastic Leukemia and Asparaginase-Associated Pancreatitis

Por Kearney, Susan L., Dahlberg, Suzanne E., Levy, Donna E., Voss, Stephan D., Sallan, Stephen E., Silverman, Lewis B.
Publicado em 2009

Population-Based Outcomes Following Endovascular and Open Repair of Ruptured Abdominal Aortic Aneurysms

Por Giles, Kristina A., Hamdan, Allen D., Pomposelli, Frank B., Wyers, Mark C., Dahlberg, Suzanne E., Schermerhorn, Marc L.
Publicado em 2009

Three-arm randomized phase II study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who w...

Por Hanna, Nasser H., Dahlberg, Suzanne E., Kolesar, Jill, Aggarwal, Charu, Hirsch, Fred R., Ramalingam, Suresh S., Schiller, Joan H.
Publicado no Cancer (2015)

Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501

Por Horn, Leora, Dahlberg, Suzanne E., Sandler, Alan B., Dowlati, Afshin, Moore, Dennis F., Murren, John R., Schiller, Joan H.
Publicado em 2009

Long-term outcomes following infrapopliteal angioplasty for critical limb ischemia

Por Lo, Ruby C., Darling, Jeremy, Bensley, Rodney P., Dahlberg, Suzanne E., Hamdan, Allen D., Wyers, Mark, Schermerhorn, Marc L.
Publicado em 2013

Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib

Por Nishino, Mizuki, Dahlberg, Suzanne E., Fulton, Linnea E., Digumarthy, Subba R., Hatabu, Hiroto, Johnson, Bruce E., Sequist, Lecia V.
Publicado no Acad Radiol (2016)

Sex Differences in Outcome with Bevacizumab Therapy: Analysis of Patients with Advanced-Stage Non-Small-Cell Lung Cancer Treated with or without Bevacizumab in Combination with Pac...

Por Brahmer, Julie R., Dahlberg, Suzanne E., Gray, Robert J., Schiller, Joan H., Perry, Michael C., Sandler, Alan, Johnson, David H.
Publicado em 2011

The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer

Por kolesar, Jill M., Dahlberg, Suzanne E., Marsh, Sharon, Mcleod, Howard L., Johnson, David H., Keller, Steven M., Schiller, Joan H.
Publicado em 2011

Randomized Phase III Study of Thoracic Radiation in Combination With Paclitaxel and Carboplatin With or Without Thalidomide in Patients With Stage III Non–Small-Cell Lung Cancer: T...

Por Hoang, Tien, Dahlberg, Suzanne E., Schiller, Joan H., Mehta, Minesh P., Fitzgerald, Thomas J., Belinsky, Steven A., Johnson, David H.
Publicado em 2012

Tumor Volume Decrease at 8 weeks is Associated with Longer Survival in EGFR-mutant Advanced Non-Small-Cell Lung Cancer Patients treated with EGFR Tyrosine Kinase Inhibitor

Por Nishino, Mizuki, Dahlberg, Suzanne E., Cardarella, Stephanie, Jackman, David M., Rabin, Michael S., Hatabu, Hiroto, Jänne, Pasi A., Johnson, Bruce E.
Publicado em 2013

Body Mass Index and its Association with Clinical Outcomes for Advanced Non-Small Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

Por Dahlberg, Suzanne E., Schiller, Joan H., Bonomi, Philip B., Sandler, Alan B., Brahmer, Julie R., Ramalingam, Suresh S., Johnson, David H.
Publicado em 2013

Interferon Alpha Plus 13-Cis-Retinoic Acid Modulation of BCL-2 Plus Paclitaxel for Recurrent Small Cell Lung Cancer (SCLC): An Eastern Cooperative Oncology Group Study (E6501)

Por Pillai, Rathi N., Aisner, Joseph, Dahlberg, Suzanne E., Rogers, John S., DiPaola, Robert S., Aisner, Seena, Ramalingam, Suresh S., Schiller, Joan H.
Publicado no Cancer Chemother Pharmacol (2014)

Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs

Por Lin, Jessica J., Cardarella, Stephanie, Lydon, Christine A., Dahlberg, Suzanne E., Jackman, David M., Jänne, Pasi A., Johnson, Bruce E.
Publicado no J Thorac Oncol (2015)

Activity of erlotinib when dosed below maximum tolerable dose for EGFR-mutant lung cancer: implications for targeted therapy development

Por Lampson, Benjamin L., Nishino, Mizuki, Dahlberg, Suzanne E., Paul, Danie, Santos, Abigail A., Jänne MD, Pasi A., Oxnard, Geoffrey R.
Publicado no Cancer (2016)

Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival

Por Nishino, Mizuki, Cardarella, Stephanie, Dahlberg, Suzanne E., Araki, Tetsuro, Lydon, Christine, Jackman, David M., Rabin, Michael S., Hatabu, Hiroto, Johnson, Bruce E.
Publicado no Eur J Radiol (2015)

Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease

Por Lo, Ruby C., Bensley, Rodney P., Dahlberg, Suzanne E., Matyal, Robina, Hamdan, Allen D., Wyers, Mark, Chaikof, Elliot L., Schermerhorn, Marc L.
Publicado em 2013